AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026Net selling: insiders sold $67.8M and bought $0 on the open market in 90 days (SEC Form 4). Congress: both buying and selling, $7K to $105K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$67.8M netNet selling
- CongressSTOCK Act, last 180 days
- $7K to $105K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 6 added, 3 cutMore adding
Market overview
Fundamentals Oct 11- Open
- $255.09
- 52-wk high
- $281.07
- High
- $261.61
- 52-wk low
- $180.57
- Low
- $254.99
- Prev close
- $256.48
- Mkt cap
- $630.04B
- P/E
- 30.3x
- Volume
- 5.46M
- Fwd P/E
- 21.0x
- Beta
- 0.21
- Div yield
- 2.04%
- P/S
- 6.4x
- P/B
- 7.6x
- Profit margin
- +21.5%
- Op margin
- +29.2%
- ROE
- +25.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about JNJ filings
Are insiders buying or selling Johnson & Johnson (JNJ) stock?
Net selling: insiders sold $67.8M and bought $0 of JNJ stock on the open market in the 90 days to Oct 12, 2026, according to SEC Form 4 filings. The largest was Duato, Joaquin (CEO and Chairman of the Board), who sold $44.7M. The latest filing was on Sep 4, 2026.
Which members of Congress have traded JNJ recently?
Rep. Lloyd Doggett (D) bought $1K to $15K on Sep 8, 2026, disclosed 27 days later. Rep. Thomas H. Kean Jr sold $1K to $15K on Aug 27, 2026, disclosed 16 days later. Sen. John Boozman (R) sold $1K to $15K on Aug 20, 2026, disclosed 22 days later. Rep. Richard Dean McCormick (R) sold $1K to $15K on Jul 30, 2026, disclosed 15 days later. In total, 4 members disclosed 7 JNJ trades with trade dates in the last 180 days, filed a median 22 days after trading.
How current is this JNJ smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- QR
Qube Research
$191.1M
bought
- SQ
Squarepoint
$138.5M
added
- MI
Millennium
$96.9M
added
What insiders are doing
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in JNJ right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 1.6% above what analysts expected.
Last report
Jul 15, 2026
Financial period
Q2 2026
Adjusted EPS
$2.85 expected
Revenue
No comparable estimate
FY2026 guidance
$100.80B to $101.40B
No comparable estimate
At a glance
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 15, 2026 | $2.90 / $2.85Yahoo Finance | +1.58% beat | $25.31B / Unavailable | Unavailable |
| Mar 31, 2026 | Apr 14, 2026 | $2.70 / $2.68Yahoo Finance | +0.85% in line | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 21, 2026 | $2.46 / $2.46Yahoo Finance | -0.11% in line | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 14, 2025 | $2.80 / $2.76Yahoo Finance | +1.49% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 16, 2025 | $2.77 / $2.68Alpha Vantage | +3.36% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 15, 2025 | $2.77 / $2.58Alpha Vantage | +7.36% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 22, 2025 | $2.04 / $2.01Alpha Vantage | +1.49% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 15, 2024 | $2.42 / $2.21Alpha Vantage | +9.50% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 13, 2026, tomorrow
Estimates as of Oct 11, 2026
EPS expected
$2.31 to $2.66
Revenue expected
9 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $23.99B | $24.56B | $24.06B | $25.31B |
| Cost of what it sold | $7.30B | $7.97B | $8.11B | $8.05B |
| Gross profit | $16.69B | $16.60B | $15.96B | $17.26B |
| What it spent | ||||
| Research and development | $3.67B | $4.25B | $3.53B | $3.65B |
| Sales and admin | $5.92B | $6.95B | $6.03B | $6.43B |
| Other operating costs | — | -$200.0M | — | — |
| Total operating expenses | $9.59B | $11.01B | $9.56B | $10.09B |
| What was left | ||||
| Operating profit | $7.10B | $5.59B | $6.39B | $7.17B |
| Interest on debt | $245.0M | $214.0M | $272.0M | $281.0M |
| Profit before tax | $7.49B | $4.97B | $5.99B | $6.75B |
| Tax | $2.34B | -$150.0M | $755.0M | $1.21B |
| Net profit | $5.15B | $5.12B | $5.24B | $5.53B |
| EBITDA | $9.29B | $7.19B | $8.27B | $8.99B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
Leans bullishOct 11Johnson & Johnson Q3 Preview: Shares Need Firm Guidance After July Fall
NeutralOct 11What To Expect In Markets This Week: JPM, GS, C Bank Earnings, CPI Report, Kevin Warsh's Speech And More
BullishOct 11Earnings Week Ahead: JPM, JNJ, BAC, GS, C, UNH, TSM, and more
Leans bullishOct 11OP Bancorp Q3 2026 Earnings Date and Estimates
NeutralOct 11Wells Fargo, Bank of America, Domino’s, Johnson & Johnson, Inflation Data, and More to Watch This Week
NeutralOct 11Better Pharma ETF: iShares IHE vs. State Street XPH
Leans bullishOct 10Johnson & Johnson (JNJ) Faces Fresh Patent Lawsuit Over Cardiology Device
Leans bearishOct 10
Macro
30 macro signals shaping JNJ right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results